This text is a result of machine translation.
The Overlooked 120 Million Consumers
Japan is a demanding but high-value market. Chinese sellers are growing fast, yet success requires more than low prices—clear manuals, strong quality, 24/7 service, and trust. Consumption is polarizing, and aging buyers remain active. Long-term branding and localization are key.
Oct 29, 2025 05:24 PM
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
EqualOcean Weekly Hotspots Series (8/17-8/22)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Aug 22, 2025 11:25 AM
Meituan's Food Delivery Brand Keeta Launches in Qatar, Plans to Enter Brazil in Months
On August 19 (local time in Qatar), Keeta, the international food delivery brand under Chinese tech and retail giant Meituan, officially launched in Doha, the capital of Qatar. This marks another layout of Keeta in the Middle East market following its entry into Saudi Arabia.
Aug 20, 2025 06:44 PM
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
EqualOcean Weekly Hotspots Series (8/10-8/15)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Aug 18, 2025 09:26 AM
EqualOcean Weekly Hotspots Series (8/3-8/8)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Aug 08, 2025 06:37 PM
Nippon instruments: the profit in the first three quarters is expected to drop by 58% - 63%
Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%
Antu biological: no impact on production and operation, emergency measures have been launched